Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jacqueline Deen & John D Clemens. (2022) Vaccine clinical trials in low- and middle-income countries: a brief review of standard, newer and proposed approaches. Expert Review of Vaccines 21:11, pages 1595-1602.
Read now
Read now
Thomas F. Wierzba. (2019) Oral cholera vaccines and their impact on the global burden of disease. Human Vaccines & Immunotherapeutics 15:6, pages 1294-1301.
Read now
Read now
Iqbal Ansary Khan, Ashraful Islam Khan, Anisur Rahman, Shah Alam Siddique, Md. Taufiqul Islam, Md. Amirul Islam Bhuiyan, Atique Iqbal Chowdhury, Nirod Chandra Saha, Prasanta Kumar Biswas, Amit Saha, Fahima Chowdhury, John D. Clemens & Firdausi Qadri. (2019) Organization and implementation of an oral cholera vaccination campaign in an endemic urban setting in Dhaka, Bangladesh. Global Health Action 12:1.
Read now
Read now
Pranab Chatterjee, Suman Kanungo & Shanta Dutta. (2018) Challenges for programmatic implementation of killed whole cell oral cholera vaccines for prevention and control of cholera: a meta-opinion. Expert Opinion on Biological Therapy 18:9, pages 983-988.
Read now
Read now
Articles from other publishers (24)
Tew Hui Xian, Subramani Parasuraman, Manickam Ravichandran & Guruswamy Prabhakaran. (2022) Dual-Use Vaccine for Diarrhoeal Diseases: Cross-Protective Immunogenicity of a Cold-Chain-Free, Live-Attenuated, Oral Cholera Vaccine against Enterotoxigenic Escherichia coli (ETEC) Challenge in BALB/c Mice. Vaccines 10:12, pages 2161.
Crossref
Crossref
Jérôme AteudjieuDavid A SackSonia Sonkeng NafackShaoming XiaoKetina Hirma Tchio-NighieHerve TchokomeniLandry Beyala Bita’aPaul Ntsekendio NyibioEtienne GuenouKedia Mayah MondungFrank Forex Kiadjieu DieumoRosanne Minone Ngome, Kelsey N. MurtMalathi RamMohammad AliAmanda K. Debes. (2022) An Age-stratified, Randomized Immunogenicity Trial of Killed Oral Cholera Vaccine with Delayed Second Dose in Cameroon. The American Journal of Tropical Medicine and Hygiene 107:5, pages 974-983.
Crossref
Crossref
Suman Kanungo, Andrew S Azman, Thandavarayan Ramamurthy, Jaqueline Deen & Shanta Dutta. (2022) Cholera. The Lancet 399:10333, pages 1429-1440.
Crossref
Crossref
Harriet Ng′ombe, Michelo Simuyandi, John Mwaba, Charlie Chaluma Luchen, Peter Alabi, Obvious Nchimunya Chilyabanyama, Cynthia Mubanga, Luiza Miyanda Hatyoka, Mutinta Muchimba, Samuel Bosomprah, Roma Chilengi, Geoffrey Kwenda & Caroline Cleopatra Chisenga. (2022) Immunogenicity and waning immunity from the oral cholera vaccine (Shanchol™) in adults residing in Lukanga Swamps of Zambia. PLOS ONE 17:1, pages e0262239.
Crossref
Crossref
Patrick G. Ilboudo, Martin A. Mengel, Bradford D. Gessner, Bagrey Ngwira, Philippe Cavailler & Jean-Bernard Le Gargasson. (2021) Cost-effectiveness of a reactive oral cholera immunization campaign using Shanchol™ in Malawi. Cost Effectiveness and Resource Allocation 19:1.
Crossref
Crossref
Placide Mbala-Kingebeni, Florian Vogt, Berthe Miwanda, Tresor Sundika, Nancy Mbula, Isaac Pankwa, Leopold Lubula, Veerle Vanlerberghe, Alain Magazani, Mildred Tita Afoumbom & Jean-Jacques Muyembe-Tamfum. (2021) Sachet water consumption as a risk factor for cholera in urban settings: Findings from a case control study in Kinshasa, Democratic Republic of the Congo during the 2017–2018 outbreak. PLOS Neglected Tropical Diseases 15:7, pages e0009477.
Crossref
Crossref
Fahima Chowdhury, Khalid Ali Syed, Afroza Akter, Taufiqur Rahman Bhuiyan, Imam Tauheed, Fatema Khaton, Rajib Biswas, Jannatul Ferdous, Hasan Al Banna, Allen G. Ross, Nigel Mc Millan, Tarun Sharma, Vibhu Kanchan, Ajit Pal Singh, Davinder Gill, Michael Lebens, Stefan Nordqvist, Jan Holmgren, John D Clemens & Firdausi Qadri. (2021) A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh. Vaccine 39:32, pages 4450-4457.
Crossref
Crossref
Jacqueline Deen & John D. Clemens. (2021) Licensed and Recommended Inactivated Oral CholeraVaccines: From Development to Innovative Deployment. Tropical Medicine and Infectious Disease 6:1, pages 32.
Crossref
Crossref
Cynthia Bonville & Joseph Domachowske. 2021. Vaccines. Vaccines
111
119
.
Vittal Mogasale, Suman Kanungo, Sanghamitra Pati, Julia Lynch & Shanta Dutta. (2020) The history of OCV in India and barriers remaining to programmatic introduction. Vaccine 38, pages A41-A45.
Crossref
Crossref
Hanif Shaikh, Julia Lynch, Jerome Kim & Jean-Louis Excler. (2020) Current and future cholera vaccines. Vaccine 38, pages A118-A126.
Crossref
Crossref
Lorenzo Pezzoli. (2020) Global oral cholera vaccine use, 2013–2018. Vaccine 38, pages A132-A140.
Crossref
Crossref
Sanjukta Sen Gupta & Nirmal Kumar Ganguly. (2020) Opportunities and challenges for cholera control in India. Vaccine 38, pages A25-A27.
Crossref
Crossref
Jayant Patwa & S.J.S. Flora. 2020. Handbook on Biological Warfare Preparedness. Handbook on Biological Warfare Preparedness
151
172
.
Francesco Grandesso, Watipaso Kasambara, Anne-Laure Page, Amanda K. Debes, Maurice M'bang'ombe, Adriana Palomares, Pauline Lechevalier, Lorenzo Pezzoli, Ian Alley, Leon Salumu, Kelias Msyamboza, David Sack, Sandra Cohuet & Francisco Javier Luquero. (2019) Effectiveness of oral cholera vaccine in preventing cholera among fishermen in Lake Chilwa, Malawi: A case-control study. Vaccine 37:28, pages 3668-3676.
Crossref
Crossref
Angèle H. M. Bénard, Etienne Guenou, Maria Fookes, Jerome Ateudjieu, Watipaso Kasambara, Matthew Siever, Stanislas Rebaudet, Jacques Boncy, Paul Adrien, Renaud Piarroux, David A. Sack, Nicholas Thomson & Amanda K. Debes. (2019) Whole genome sequence of Vibrio cholerae directly from dried spotted filter paper. PLOS Neglected Tropical Diseases 13:5, pages e0007330.
Crossref
Crossref
David J. Williams, Mohd Abul Faiz, Bernadette Abela-Ridder, Stuart Ainsworth, Tommaso C. Bulfone, Andrea D. Nickerson, Abdulrazaq G. Habib, Thomas Junghanss, Hui Wen Fan, Michael Turner, Robert A. Harrison & David A. Warrell. (2019) Strategy for a globally coordinated response to a priority neglected tropical disease: Snakebite envenoming. PLOS Neglected Tropical Diseases 13:2, pages e0007059.
Crossref
Crossref
Frederik Federspiel & Mohammad Ali. (2018) The cholera outbreak in Yemen: lessons learned and way forward. BMC Public Health 18:1.
Crossref
Crossref
William Davis, Rupa Narra & Eric D. Mintz. (2018) Cholera. Current Epidemiology Reports 5:3, pages 303-315.
Crossref
Crossref
Sung Kang, Seok Hong, Yong-Kyu Lee & Sungpil Cho. (2018) Oral Vaccine Delivery for Intestinal Immunity—Biological Basis, Barriers, Delivery System, and M Cell Targeting. Polymers 10:9, pages 948.
Crossref
Crossref
Robert H. Hall. (2018) Curbing cholera. Science Translational Medicine 10:445.
Crossref
Crossref
Louise C Ivers. (2018) Cholera control: one dose at a time. The Lancet Infectious Diseases 18:6, pages 591-592.
Crossref
Crossref
Patrick G. Ilboudo & Jean-Bernard Le Gargasson. (2017) Delivery cost analysis of a reactive mass cholera vaccination campaign: a case study of Shanchol™ vaccine use in Lake Chilwa, Malawi. BMC Infectious Diseases 17:1.
Crossref
Crossref
Amber HsiaoSachin N DesaiVittal MogasaleJean-Louis ExclerLaura Digilio. (2017) Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings. Bulletin of the World Health Organization 95:4, pages 303-312.
Crossref
Crossref